Global Pharma 4 — March 20th 2026.
Not a course.
A mindset shift for those shaping the future of pharma.
Apply now for the 4th Edition and get 25% off €625 discount
Early applications are open until December 30th
Seats are highly limited, and every application is reviewed individually by the GenH team.
We select people who will elevate the conversation.
Total value: €2,500 Early offer: €1,875
This is a
Learn & Act Course
Our Learn & Act model combines expert-led learning with hands-on application. Participants first gain advanced insights and skills, then collaborate to tackle a real-world business case from an actual company.
Top Leaders at GP4
André de Aragão Azevedo
Former Secretary of State for Digital Transition and Private Investor
Teresa Guerreiro
Market Access, Pricing & HTA
Senior Consultant
Hugo Barbosa
EU Customer Omnichannel Director
at ViiV Healthcare
Tarkan Dogru
Head Technical Development Synthetic Molecules at Roche
Sofia Ferreira
Country Lead PT, UK and Nordics
at Organon
André Correia
Executive VP at SERaro.pt
Hélder Romão
Partner at DSR + Head of Marketing & Creativity at GenH
Ana Cadete
CMC Project Leader
at Sanofi
Filipa Mota e Costa
Managing Director at J&J Innovative Medicine Portugal
Paulo Teixeira
Country Manager at Pfizer Portugal
Paula Rosa
Senior Director Product
Strategy at Roche
Paulo Barradas Rebelo
Chairman at Bluepharma
Paula Martins de Jesus
Medical Director at MSD
Sérgio Alves
Operations Director at Ascendis Pharma - Portugal
Nina Fernandes
Medical Advisor Oncology at MSD Portugal
Daniel Guedelha
Founder & CEO at GenH
Knowledge partners
GenH Alumni Community
You’re not just joining a program! you’re entering a global network of leaders from the world’s most impactful companies.
-
As this course is designed for extensive interaction with the Professors and the students, it requires physical presence.
-
The course is expected to start in March 2026 and take place every week on: Fridays (starting 17h00) and Saturdays (09h00-13h00).
-
Most of the sessions will be in Portuguese. There may be sessions in English, as we will also have international speakers.
-
Yes. A participation diploma will be provided at the end of the course and if the students comply with the needed requirements.
-
Yes. You do not need to be sponsored by your company to undertake this course.
-
Yes. The course is exactly designed to have lots of interactions with the senior leaders that will give the lectures.
-
No. This course was not designed to provide theoretical but mostly practical information.
-
This is a short course and not a post graduation.
“This course encourages innovation and entrepreneurship in the health sector, offering fundamental tools for any role in the Pharmaceutical Industry.”
Margarida Gaião,
Medical Science Liaison
Radioligand Therapies
at Novartis Portugal
GP1 Participant
“This course was a milestone in acquiring the most current knowledge about the Pharmaceutical Industry in Portugal and the world”
Rui Pardelha,
Territory Manager Middle East , Turkye and Africa
GP1 Participant
"Participating in this course was an incredible experience, where a diversity of colleagues from different areas inspires us to explore curiosity and creativity, to think innovatively and build solutions for better access to healthcare for our patients"
Susana Moreira,
Regulatory Affairs Manager
Spain & Portugal at Sandoz Iberia
GP2 Participant
